Biosynex
Designs and distributes medical diagnostic solutions, including rapid tests and devices.
ALBIO | PA
Overview
Corporate Details
- ISIN(s):
- FR0011005933
- LEI:
- 969500H4BGE1HBLGP566
- Country:
- France
- Address:
- 22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.biosynex.com/en/
- Sector:
- Manufacturing
Description
Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-13 08:00 |
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
|
French | 120.7 KB | ||
| 2025-02-12 08:00 |
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
|
French | 120.7 KB | ||
| 2025-02-12 08:00 |
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
|
French | 120.7 KB | ||
| 2025-01-22 07:00 |
BIOSYNEX SA: LANCEMENT D’UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PRE…
|
French | 543.0 KB | ||
| 2025-01-22 07:00 |
BIOSYNEX SA: LANCEMENT DUNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREF…
|
French | 318.4 KB | ||
| 2025-01-13 18:15 |
BIOSYNEX SA: CROISSANCE DE L’ACTIVITE EN 2024 - POURSUITE DE LA RESTRUCTURATION…
|
French | 344.1 KB | ||
| 2025-01-13 18:15 |
BIOSYNEX SA: CROISSANCE DE LACTIVITE EN 2024 - POURSUITE DE LA RESTRUCTURATION …
|
French | 58.8 KB | ||
| 2024-12-19 18:00 |
BIOSYNEX SA: Calendrier financier 2025
|
French | 293.3 KB | ||
| 2024-12-02 08:00 |
BIOSYNEX ANNONCE AVOIR TROUVE UN ACCORD DE PRINCIPE AVEC SES PRINCIPAUX CREANCI…
|
French | 384.2 KB | ||
| 2024-11-04 18:00 |
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 OCTOB…
|
French | 124.2 KB | ||
| 2024-10-23 18:00 |
BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRA…
|
English | 242.8 KB | ||
| 2024-10-23 18:00 |
BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC, FILIALE DE BIOSYNEX, REÇOIT UNE SUBVENTIO…
|
French | 262.6 KB | ||
| 2024-10-17 18:00 |
BIOSYNEX SA: RESULTATS SEMESTRIELS 2024 - FINALISATION DU PLAN DE RATIONALISATI…
|
French | 394.8 KB | ||
| 2024-07-18 18:00 |
BIOSYNEX SA: CA DU S1 2024 EN CROISSANCE : 53,8 M€ (+26% DONT +6% ORGANIQUE) - …
|
French | 270.1 KB | ||
| 2024-05-28 17:45 |
BIOSYNEX SA: BIOSYNEX ANNONCE L’OBTENTION DE SES PREMIERS MARQUAGES CE SELON LA…
|
French | 324.6 KB |
Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biosynex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biosynex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
